These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5573981)

  • 1. [Quantitative determination of delta-aminolevulinic acid and porphobilinogen in urine, using ion exchange chromatography columns].
    Doss M; Schmidt A
    Z Klin Chem Klin Biochem; 1971 Mar; 9(2):99-102. PubMed ID: 5573981
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of glycine loading on Delta-Aminolevulinic acid (ALA) and porphobilinogen (PBG) excretion during starvation.
    Deleña S; Brown H
    Metabolism; 1969 Nov; 18(11):901-5. PubMed ID: 5350555
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new method for the clinical determination of urinary porphobilinogen and delta-aminolevulinic acid].
    Schmidt M; Eisenburg J
    Fortschr Med; 1977 Mar; 95(10):653-8. PubMed ID: 14874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The etiology of the neuropathy in acute intermittent porphyria.
    Zimmerman EA; Lovelace RE
    Trans Am Neurol Assoc; 1968; 93():294-6. PubMed ID: 5711046
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 7. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.
    Miyagi K; Cardinal R; Bossenmaier I; Watson CJ
    J Lab Clin Med; 1971 Nov; 78(5):683-95. PubMed ID: 5128821
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis of a case of acute intermittent porphyria with the aid of thin-layer chromatography-thin-layer electrophoresis of urine.
    Samuels S; Veliz G
    Clin Chem; 1971 Jan; 17(1):51-2. PubMed ID: 5538582
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute intermittent porphyria. A clinical and biochemical study of 46 patients.
    Stein JA; Tschudy DP
    Medicine (Baltimore); 1970 Jan; 49(1):1-16. PubMed ID: 4907358
    [No Abstract]   [Full Text] [Related]  

  • 10. [A family study of porphyrias].
    Hänninen P
    Duodecim; 1969; 85(21):1349-55. PubMed ID: 5371715
    [No Abstract]   [Full Text] [Related]  

  • 11. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Appraisal of the methods of expressing lead concentrations and porphyrin precursors in the urine].
    Iliescu S; Stavri G; Freund S; Vasilíu A
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(4):955-60. PubMed ID: 5370591
    [No Abstract]   [Full Text] [Related]  

  • 13. [Simplified determination of delta aminolevulinic acid in urine].
    Simon KH
    Med Monatsschr; 1967 Apr; 21(4):187-8. PubMed ID: 5584447
    [No Abstract]   [Full Text] [Related]  

  • 14. Hereditary hepatic prophyrias. Gene penetration, drug sensitivity and subdivision in the light of systematic family studies.
    With TK
    Acta Med Scand; 1969; 186(1-2):117-24. PubMed ID: 5807639
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions.
    Bossenmaier I; Cardinal R
    Clin Chem; 1968 Jul; 14(7):610-4. PubMed ID: 5663456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of urinary delta-aminolevulinic acid].
    Büchner M; Ramm B; Nowack A; Winkler U
    Z Med Labortech; 1973; 14(1):50-5. PubMed ID: 4699185
    [No Abstract]   [Full Text] [Related]  

  • 17. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
    TAYLOR JD; PAZDER LH; MARKLE V
    Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of the urinary delta-aminolevulinic acid test to detect pediatric lead poisoning.
    Blanksma LA; Sachs HK; Murray EF; O'Connell MJ
    Am J Clin Pathol; 1970 Jun; 53(6):956-62. PubMed ID: 5515391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simplified determination of delta-aminolevulinic acid in the urine].
    Rehpenning W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(2):241-5. PubMed ID: 4111659
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of the urinary delta aminolevulinic acid. Levels in a Spanish population].
    Tutor Valcarce JC; Trigo Vázquez E; García Devesa J; del rio Anido R
    Rev Clin Esp; 1976 Aug; 142(3):205-9. PubMed ID: 968109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.